 |
|
|
 |
|
Drug Reduces Inflammatory Arthritis Symptoms, Lesions
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 The study was published online and was expected to be in an upcoming print issue of The Lancet.
"The efficacy of ustekinumab for improving skin and joint involvement, which was maintained for several months, combined with good tolerability and a benign safety profile, make this agent an attractive option in psoriatic arthritis," Dr. Raquel S. Cuchacovich and Dr. Luis R. Espinoza, of LSU Health Sciences Center in New Orleans, wrote in an accompanying editorial.
More information
Text Continues Below

The National Psoriasis Foundation has more about psoriatric arthritis.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 2/12/2009
|
 |

SOURCE: The Lancet, news release, Feb. 11, 2009
|